Status:
UNKNOWN
Protein Classifier for Thyroid Indeterminate Nodules
Lead Sponsor:
Luo Dingcun
Conditions:
Thyroid Nodule
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
In multi-center, prospective, double-blind cohorts, PCT-DIA/MS protein classifier supported by artificial neural networks will be validated to classify thyroid indeterminate nodules.
Eligibility Criteria
Inclusion
- Patients with aged 18 to 70 years old;
- Patients with thyroid nodules who have not been treated with drugs;
- Patients who were diagnosed as Bethesda III and IV by cytology and pathology before operation;
- Patients who underwent total / partial thyroidectomy and had histopathological reports of corresponding cellular pathological punctured nodules;
- Patients voluntarily participate in the study after informed consent.
Exclusion
- Patients without operation;
- Patients with insufficient FNA sample size (judged by the laboratory).
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04477798
Start Date
August 1 2020
End Date
December 31 2021
Last Update
July 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hangzhou First People's Hospital Affiliated to Zhejiang University Medical College
Hangzhou, Zhejiang, China, 317500